These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 4453682)

  • 1. The treatment of myotonia with L-dopa. I. Clinical and electromyographic study.
    Pendefunda GH; Stefanache F; Cozma V
    Rev Med Chir Soc Med Nat Iasi; 1974; 78(3):591-602. PubMed ID: 4453682
    [No Abstract]   [Full Text] [Related]  

  • 2. The treatment of miotonia with L-dopa. II) The dynamic study of medullary excitation.
    Pendefunda GH; Stefanache F; Teodorescu C; Costan C
    Rev Med Chir Soc Med Nat Iasi; 1974; 78(4):779-86. PubMed ID: 4453713
    [No Abstract]   [Full Text] [Related]  

  • 3. Severity, type, and distribution of myotonic discharges are different in type 1 and type 2 myotonic dystrophy.
    Logigian EL; Ciafaloni E; Quinn LC; Dilek N; Pandya S; Moxley RT; Thornton CA
    Muscle Nerve; 2007 Apr; 35(4):479-85. PubMed ID: 17230537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myotonic dystrophy: limited electromyographic abnormalities in 2 definite cases.
    Sun SF; Streib EW
    Clin Genet; 1983 Feb; 23(2):111-4. PubMed ID: 6839522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The problem of diagnosis and therapy of myotonic dystrophy].
    Reisecker F; Markut H; Tulzer W
    Wien Med Wochenschr; 1983 Jun; 133(12):319-21. PubMed ID: 6613149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible role of apamin-sensitive K+ channels in myotonic dystrophy.
    Behrens MI; Jalil P; Serani A; Vergara F; Alvarez O
    Muscle Nerve; 1994 Nov; 17(11):1264-70. PubMed ID: 7935548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Myotonic dystrophy].
    Nesterov LN; Sushcheva GP; Viatkina SIa; Nesterova IM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1983; 83(11):1636-41. PubMed ID: 6232784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Syndromology of progressive muscular dystrophy, myotonia, dystrophic myotonia and myasthenia in light of electromyography].
    Steinbrecher W
    Psychiatr Neurol Med Psychol Beih; 1969; 10-11():166-71. PubMed ID: 5006335
    [No Abstract]   [Full Text] [Related]  

  • 9. Nifedipine in the treatment of myotonia in myotonic dystrophy.
    Grant R; Sutton DL; Behan PO; Ballantyne JP
    J Neurol Neurosurg Psychiatry; 1987 Feb; 50(2):199-206. PubMed ID: 3553433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Central genesis of dystrophia myotonica and Tegretal therapy].
    Jusić A; Stimac D
    Fortschr Neurol Psychiatr Grenzgeb; 1972 Feb; 40(2):105-12. PubMed ID: 4481995
    [No Abstract]   [Full Text] [Related]  

  • 11. Fluoxetine blocks myotonic runs and reverts abnormal surface electromyogram pattern in patients with myotonic dystrophy type 1.
    Chisari C; Licitra R; Pellegrini M; Pellegrino M; Rossi B
    Clin Neuropharmacol; 2009; 32(6):330-4. PubMed ID: 19667977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative testing of handgrip strength, myotonia, and fatigue in myotonic dystrophy.
    Torres C; Moxley RT; Griggs RC
    J Neurol Sci; 1983 Jul; 60(1):157-68. PubMed ID: 6875612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electromyography in the evaluation of muscle diseases.
    Buchthal F
    Neurol Clin; 1985 Aug; 3(3):573-98. PubMed ID: 3900682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An electromyographic study of multiple cases of myotonia atrophica in one same family.
    Rosselle N; Stevens A; Sonck W; Bonne A; Faes MH; Broux G; Steens H; Heymans W
    Electromyography; 1970; 10(4):415-24. PubMed ID: 5521841
    [No Abstract]   [Full Text] [Related]  

  • 15. Myotonic dystrophy: relative sensitivity of symptoms signs and abnormal investigations.
    Avaria M; Patterson V
    Ulster Med J; 1994 Oct; 63(2):151-4. PubMed ID: 8650827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinico-electromyographic and electroneuromyographic characteristics of myotonias].
    Avakian GN; Aslanov AM; Odilzhonov TO; Antipin ES
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(3):335-8. PubMed ID: 3705838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative study of disopyramide and procainamide in the treatment of myotonia in myotonic dystrophy.
    Finlay M
    J Neurol Neurosurg Psychiatry; 1982 May; 45(5):461-3. PubMed ID: 7045292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of dantrolene sodium in myotonic dystrophy.
    Mamoli B; Dal-Bianco P; Zeitlhofer K
    Eur Neurol; 1983; 22(1):29-34. PubMed ID: 6840139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical study of paramyotonia congenita with and without myotonia in a warm environment.
    Haass A; Ricker K; Rüdel R; Lehmann-Horn F; Böhlen R; Dengler R; Mertens HG
    Muscle Nerve; 1981; 4(5):388-95. PubMed ID: 6793868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary function and electromyographic study of respiratory muscles in myotonic dystrophy.
    Jammes Y; Pouget J; Grimaud C; Serratrice G
    Muscle Nerve; 1985 Sep; 8(7):586-94. PubMed ID: 4047090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.